Fresenius SE & Co. KGaA

Earnings Release • Feb 22, 2006

News Details

Ad-hoc | 22 February 2006 07:31

Fresenius AG: 2005 Full Year Results

Ad hoc announcement transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— Fiscal Year 2005: Excellent sales and earnings growth 13th consecutive dividend increase proposed Outlook 2006: Sales of approx. € 10.5 billion and net income growth of more than 30 % expected Fresenius Group achieved excellent financial results in 2005. Sales rose 8 % in constant currency and at actual rates to EUR 7,889 million (2004: EUR 7,271 million). EBIT increased 15 % at actual exchange rates and 14 % in constant currency to EUR 969 million (2004: EUR 845 million). Net income rose 32 % at actual exchange rates and 31 % in constant currency to EUR 222 million (2004: EUR 168 million). Excellent operating results of Fresenius Medical Care and Fresenius Kabi, lower interest expenses and a lower tax rate contributed to this increase. Earnings per ordinary share were EUR 5.28 (2004: EUR 4.08). Earnings per preference share were EUR 5.31 (2004: EUR 4.11). The Management Board will propose to the Supervisory Board a dividend increase to EUR 1.48 per ordinary share (2004: EUR 1.35) and EUR 1.51 per preference share (2004: EUR 1.38). For 2006, Fresenius expects to achieve sales growth of about 30 % to approximately Euro 10.5 billion including Renal Care Group and an organic growth of 5-6 %. Net income is projected to grow by more than 30 % in constant currency. The net income guidance already includes an amount of approx. Euro 30 million (after tax) associated with expected one-time expenses for the integration of Renal Care Group and the refinancing of debt as well as for costs related to the change of accounting principles for stock options. Due to the higher number of shares issued in December 2005, earnings per share are projected to increase by approximately 10 % in constant currency. (Financial statements according to US-GAAP) The Management Board Bad Homburg v.d.H., February 22, 2006 (c)DGAP 22.02.2006 ————————————————————————— language: English emitter: Fresenius AG Else-Kröner-Straße 1 61352 Bad Homburg v.d.H. Deutschland phone: +49 (0)6172 608-2485 fax: +49 (0)6172 608-2488 email: ir-fre@fresenius.de WWW: www.fresenius.de ISIN: DE0005785638, DE0005785604 WKN: 578563, 578560 indexes: MDAX stockmarkets: Amtlicher Markt in Frankfurt, Düsseldorf, München; Freiverkehr in Berlin-Bremen, Hamburg, Stuttgart End of News DGAP News-Service —————————————————————————